Inventor · disambiguated record
Richard David Taylor
Also filed as: TAYLOR RICHARD DAVID
11 granted patents·4 pending applications·64 citations·filing 2005–2023
85Inventor score
Files withUCB Biopharma SRL9BERDINI VALERIO2UCB BIOPHARMA SPRL2CANCER REC TECH LTD1WELLCOME TRUST LTD1
Top patents by PatentIndex Score
15 records- 0192US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 0286US7625922B2Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compoundsCANCER REC TECH LTD·Filed 2005·Granted Dec 1, 2009·19 cites·44 claims
- 0383US8513276B2Imidazo[1,2-a]pyridine compounds for use in treating cancerBERDINI VALERIO·Filed 2007·Granted Aug 20, 2013·8 cites·16 claims
- 0473US10464932B2Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitorsUCB BIOPHARMA SPRL·Filed 2017·Granted Nov 5, 2019·1 cites·15 claims
- 0567US7737152B26-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compoundsWELLCOME TRUST LTD·Filed 2005·Granted Jun 15, 2010·3 cites·27 claims
- 0662US2025134890A1Antimalarial hexahydropyrimidine analoguesUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 0755US2024294534A1Imidazotriazine derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 0851US11479546B2Antimalarial hexahydropyrimidine analoguesUCB Biopharma SRL·Filed 2019·Granted Oct 25, 2022·0 cites·18 claims
- 0949US12391688B2Imidazopyridine derivatives as IL-17 modulatorsUCB Biopharma SRL·Filed 2020·Granted Aug 19, 2025·0 cites·10 claims
- 1048US2022289685A1Antimalarial hexahydropyrimidine analoguesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 1145US11472794B2Fused imidazole derivatives as IL-17 modulatorsUCB Biopharma SRL·Filed 2019·Granted Oct 18, 2022·0 cites·12 claims
- 1244US12327613B2De novo antibody designUCB Biopharma SRL·Filed 2016·Granted Jun 10, 2025·0 cites·22 claims
- 1343US2022242855A1Fused Imidazole Derivatives as IL-17 ModulatorsUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 1441US11136310B2Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitorsUCB BIOPHARMA SPRL·Filed 2016·Granted Oct 5, 2021·0 cites·10 claims
- 1538US11052076B2Spirocyclic indolines as IL-17 modulatorsUCB Biopharma SRL·Filed 2018·Granted Jul 6, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Richard David Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →